MATTERHORN, ATOMIC, CHALLENGE, and More
July 22nd, 2025
Dr. Weinberg recaps key gastrointestinal cancer highlights from the 2025 ASCO Annual Meeting.…
New Lombardi Research
Study Finds New Targeted Therapy Slows Growth in Rare NRG1 Fusion Tumors.
Learn More:
GI Cancer in the News
Dr. Marshall discusses the rise in early-age onset Colorectal Cancer and how researchers are working to
uncover the reasons for this sharp increase.
The 2025 Ruesch Center Symposium
Register Today for the 16th Annual Ruesch Center Symposium
Learn More:
Give to the Ruesch Center Today
One of the most meaningful gifts you can give cancer patients and their families is hope.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
Discover how genetic testing can help identify these rare treatment targets
July 22nd, 2025
New Lombardi research shows that a safe and effective targeted therapy can slow tumor growth in patients with some types of pancreatic and lung cancers. …
EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer
July 22nd, 2025
Dr. Weinberg discusses promising early results from the EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer. …
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver information on upcoming educational events, current clinical trials, and cutting-edge research and trends in the GI cancer field.